|
SNX12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.806920E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.836700E-04 |
| Normal-vs-Stage2 |
1.322270E-02 |
| Normal-vs-Stage3 |
2.822800E-04 |
| Normal-vs-Stage4 |
2.787300E-04 |
| Stage1-vs-Stage2 |
8.500400E-01 |
| Stage1-vs-Stage3 |
4.854200E-01 |
| Stage1-vs-Stage4 |
3.910600E-01 |
| Stage2-vs-Stage3 |
5.196200E-01 |
| Stage2-vs-Stage4 |
3.994400E-01 |
| Stage3-vs-Stage4 |
7.593800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.028800E-04 |
| Normal-vs-AfricanAmerican |
1.433210E-01 |
| Normal-vs-Asian |
4.104100E-03 |
| Caucasian-vs-AfricanAmerican |
3.098000E-01 |
| Caucasian-vs-Asian |
8.745200E-01 |
| AfricanAmerican-vs-Asian |
3.352200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.33969999999751E-07 |
| Normal-vs-Female |
1.715210E-03 |
| Male-vs-Female |
1.279690E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.096600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.394770E-04 |
| Normal-vs-Age(61-80Yrs) |
8.407700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.519840E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.001200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.329200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.012600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.164000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.913000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.464600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.982200E-01 |
| Classical-VS-Follicular |
1.344190E-01 |
| Classical-VS-Other |
6.400000E-02 |
| Classical-VS-Normal |
1.937050E-03 |
| Tall-VS-Follicular |
7.839800E-01 |
| Tall-VS-Other |
1.383560E-01 |
| Tall-VS-Normal |
3.204400E-03 |
| Follicular-VS-Other |
2.997600E-01 |
| Follicular-VS-Normal |
3.246700E-04 |
| Other-VS-Normal |
2.540600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.371500E-04 |
| Normal-vs-N1 |
6.48930000000103E-05 |
| N0-vs-N1 |
1.142040E-01 |
|
|
